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Summary
'Abbreviation used in this paper. UTR, untranslated region .
In the mouse and human,mRNA transcripts encoding the lymphocyte-specific protein tyrosine
kinase p56ikk are derived from two separate promoters resulting in heterogeneity in the 5'
untranslated region sequence. The proximal promoter lies just 5' to the coding region for the
gene and is active only in thymocytes . In contrast, the distal promoter lies 34 kilobases (kb)
5' in the human, and is active both in thymocytes and mature peripheral T cells . As previously
reported, transgenic mice bearing functional proximal promoter sequence juxtaposed with the
SV40 large T antigen gene invariably develop lymphoid tumors confined to the thymus. In the
current work, transgenic mice bearing a 2.6-kb fragment of the human distal promoter fused
to the SV40 largeT antigen gene express largeT antigen in thymocytes and in peripheral lymphoid
cells, and develop tumors of both the thymus and the peripheral lymphoid organs . The ability
of the human distal promoter to function appropriately in transgenic mice is consistent with
the strong similarity observed between the mouse and human distal promoter sequences . With
the exception ofa single short interval that serves as a target for binding of nuclear factors, significant
sequence similarity is not seen when the distal and proximal promoter sequences are compared .
Hence, developmentally regulated, lineage-specific transcription of the Ick gene is mediated by
distinct promoter sequences that appear to be capable of functioning independently.
T
he kk gene encodes a membrane-associated protein tyro-
sine kinase (p56") that is expressed in cells of the lym-
phoid lineage, primarily T cells, lymphoid tumor cell lines,
and a few nonlymphoid tumors (1-3) . While the precise func-
tion of p56i" in T cells remains undefined, it physically as-
sociates with the cytoplasmic tails ofCD4 and CD8 coreceptor
molecules (4-6) . Hence it is believed that p56kk may interact
with the T cell antigen recognition complex and participate
in an antigen-stimulated signal transduction pathway (7) .
We and others have shown that kk transcripts derived from
certain cultured cell lines are heterogeneous with respect to
the nucleotide sequence of the 5' untranslated region (5'
UTR)l (2, 6, 8-10) . The two major transcript types seen
in the cell lines, type I and type II, are derived from two
alternative promoters. Transcription from a conserved pro-
moter region contiguous with the Ick coding sequence (the
proximal promoter) results in type I transcripts. Type II tran-
scripts are derived by splicing ofa larger transcript originating
at another promoter separated by many kb from the coding
sequence (the distal promoter) (6, 8, 11) . Since the splice ac-
ceptor site for the type 11 RNA precursor is just 5 by 5' to
the translation initiation codon, almost the entire 5' UTR
sequence of type 11 Ick transcripts differs from that of type I .
We do not know whether these results in cultured, often
transformed cell lines reflect the true state of transcription
in normal cells. Garvin et al. (8) have shown that transcripts
containing type I and type 115' UTRs are both present in
normalhuman thymus RNA, suggesting that alternative pro-
moter usage also occurs in normal human T cells. With this
exception, the expression patterns of type I and type 11 Ick
mRNAs in normal lymphoid cells have not been examined .
To better define the regulation of Ick gene expression, we
have cloned genomicDNA fragments containing the human
and mouse distal Ick promoters, and have sequenced the regions
flanking the transcription start sites . While thesemouse and
human sequences are very similar to one another, they share
little similarity with the proximal promoter sequences from
either species . Nonetheless, a short region with a high con-
servation between distal and proximal promoters was identified
and found to be sufficient to bind nuclear proteins in a
sequence- and tissue-specific manner. We demonstrate that
type I and type II transcripts are differentially expressed in
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and that the proximal and distal promoter elements can func-
tion independently in transgenic mice.
Materials and Methods
Genomic Libraries andLibrary Screening .
￿
Human cloneSP2 (Fig.
1 a) was isolated from a genomic cosmid library (8) by hybridiza-
tion screening with the human Ick cDNA clone HK28 (2) using
established procedures (8). A mapwas generatedby analysis of re-
striction fragments and overlapping cosmids. Mouse clone32.1 (Fig .
1 b) containing a 15.5-kb insert was isolated from a Charon 4A
phage library of AluI and HaelII partially digested BALB/c mouse
spermDNA (12) by hybridization screening with a 51 by synthetic
double-stranded oligonucleotide (5-'AGGCTAGGAGCATCATG-
TGAATAGGCCAGAAGGCTCCCAGGCTGGGCAGG-3') specific
for the 5' UTRsequence of mouse type II transcripts (13) . Plating
of the phage, screeningby hybridization, isolation, and large scale
culture were performed as previously described (1) .
DNA Sequencing and Sequence Analysis.
￿
Nucleotide sequence
was determined by the Sanger dideoxy chain-termination method
(14) using specific oligonucleotide primers applied to both strands
of double strandedpUC18 orpUC19 plasmids containing the ap-
propriate SP2 and 32 .1 subclones.
Dotmatrix comparisons, repeat analysis, and small-scale similarity
searches were performed on a microcomputer running Genepro
software (Riverside Scientific Enterprises, Seattle, WA). Theparam-
eters for dot matrix comparisons were chosen empirically so as to
strictly limit thenumber of matches occurring randomly. Sequence
alignments were performed piece-wise in theprogram Nucaln (D. J.
Lipman, Bethesda, MD) using a K-tuple of 3, window size of
20, and gap penalty of 7, and then pieced together manually for
best fit . The EMBL19 DNA sequence library was searched within
PC-GENE (Intelligenetics, Inc., Mountain View, CA) .
RNABlotting andRNAase Protection .
￿
Human peripheral blood
T cells were isolated as previously described (15, 16) . Human thymo-
cytes were subjected to complement lysis after incubation with ei-
ther anti-CD4 (66.1), anti-CD8 (OKT8), or both monoclonal an-
tibodies, as described (15) . The efficiency of the separation was
checked by flow cytometry ofthe surviving cells stained with con-
jugated antibodies specific for CD3e, CD4, CD8, and -yb TCR.
Total cellular RNA was prepared from the resulting cells by the
guanidinium thiocyanate/cesium chloride method (17) . 5 pg of
RNAwere analyzed in each lane by electrophoresis in 2.2Mform-
aldehyde/1% agarose gels and blotted as described (18) . Blots were
hybridized at 42°C in Southern blot buffer with 50% formamide
(19) with a denatured synthetic double-stranded64 by ['1P]-labeled
DNA probe specific for the 5' UTRs of type II human Ick tran-
scripts (bases +42 to +105). After autoradiography, the blot was
stripped of probe by boiling and reanalyzed with a 64 by probe
specific for the human type 15'UTR (bases +41 to +104) . The
probes were constructed and labeled as describedbelow. After each
hybridization, the blot was washed to a final stringency of 50°C
in 1x SSC, 0.1% SDS (19) . Densitometry was performed on a
digitized video image using Visage software (Bio Image, Ann
Arbor, MI) .
Whole cellular RNA samples from normal mouse thymocytes
and LN cells were analyzed by RNAase protection as described
(9) . The antisense IckRNAprobewas transcribed from a subcloned
SfaN1-EcoRI mouse genomic fragment spanning the 5' UTR of
type I Ick transcripts, the first exon, and the flanking promoter
(5') and intron (3) sequences (Fig. 2 a) . TheCD4 RNA probe
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was made in a similar fashion from a 145 by Xhol-Pstl fragment
from the 5' end of the mouse CD4 cDNA (20) .
GelMobility ShiftAssay .
￿
Extracts of nuclear proteins were pre-
pared from the organs of freshly sacrificed normal mice as described
(21), except that protease inhibitors were not added. Labeled probe
was run on a 0.4 mm thick, 16% polyacrylamide gel and eluted
from the gel slice into water. Extracts were incubated with DNA
essentially as described (21) . Briefly, 2-5 p,l of extractwasincubated
with 1.5 hg of poly dIdC (Sigma Chemical Co., St . Louis, MO)
for 15 min at 4°C in a total volume of 8 pl . 10 ng (1 /Al) of unla-
beled competitor DNA, or water, was then added, and after 10
min at room temperature, 10^cpm (N60 pg) of labeled probe was
added andthemixture incubated for an additional 25 min . Samples
were run on a 0.8 x 140 x 170-mm, 6% polyacrylamide gel at
175V for 2 h at 4°Cwith recirculation of the buffer (50mM Tris-
Cl, 1mM EDTA,pH 8.5), the gelwas dried, andautoradiographed .
Oligonucleotide Probes and Competitors.
￿
Short, double-stranded
DNAfragmentswere prepared for use as probes or unlabeledcom-
petitors by annealing pairs ofsyntheticDNAoligonucleotides that
are complementary at their 3' ends in 50 mM NaCl, 10 mM Tris-
Cl, pH 7.5, 6 MM MgC12, 3 mM dithiothreitol for 15 min at
37°C, then adding the four deoxynucleotide triphosphates to 30
p.M and filling in the recessed ends with Klenow fragment at room
temperature for 5-10 min . For radiolabeled probes, ["P]dATP was
substituted for dATP in the Klenow step, and chased with unla-
beleddATP for an additional 5 min . Competitors prepared for use
in gel mobility shifts were phenol/chloroform extracted, precipi-
tated with ethanol, and redissolved in water before use .
Transgenic Animals.
￿
The human genomic clone SP12 (Fig. 1
a) which includes 2.5 kb of the region 5' to the human type II
transcription start site (i.e ., the distal Ick promoter)wasjuxtaposed
with a StuI-BamHI fragment ofthe SV40 genome containing the
gene for largeand small T antigen (22) to constructaclone called
SP12T . Mice transgenic for this construct were generated as previ-
ously described (22) . Animals were sacrificed at various ages or
when they appeared ill . Tumors were visualized upon gross dissec-
tion andconfirmed in some cases by histology. Cells from tumors
and normal appearing lymphoid organs were suspended in solu-
tion, stained with fluorescence-conjugated antibodies to mouse
CD4, CD8, andCD3e,andanalyzed for the presence ofthose mol-
ecules and for size (forward scatter) by flow cytometry as previ-
ously described (22) . Northern blot of tissue RNA from a trans-
genic mousewas prepared as described aboveandprobed with the
Stul-BamHI SV40 T antigen gene fragment labeled by random
priming (19) .
Results
TheHumanDistal Ick Promoter Resides 34 kb 5' ofthe Prox-
imal Promoter . Though the presumed mechanism by which
type II kk transcripts are generated is via splicing of aprecursor
mRNA derived from the distal promoter, physical linkage
of these sequences hasnotbeen shown. By screening a human
genomic cosmid library, we isolated a single cosmid clone
(SP2) containing both type I and type 11 5'UTR sequences.
Mapping of the entire region by subeloning, restriction en-
zyme analysis, and sequencing demonstrated that the type
II transcription start site is positioned 34 kb 5' to that of
thetype Ikk transcripts inhumanDNA (Fig. 1 a) . The fidelity
of the cosmid was confirmed by genomic blotting analyses
(data not shown) . The long interval separating these tran-b
I kb
32.1
Figure 1 .
￿
Structure of the human and murine kk genomic clones . (a)
Map of the human genomic cosmid clone SP2 containing the proximal
and distal kk promoter regions. SP5 and SP12 are 2.1- and 2.6-kb sub-
clones of SP2 containing sequences flanking the proximal and distal pro-
moter transcription start sites, respectively. The cosmid vector arms are
not shown. (b) Restriction map of the mouse genomic phage clone 32 .1
containing the distal kk promoter region . Left arm and right arm refer
to the phage arms. Open bars represent 5' UTRs. Restriction sites (map
in a may not include all sites for every enzyme) : C, Clal ; B, BamHI ; H,
HindIII ; Sm, Smal; E, EcoRl ; P, Pstl .
scriptional units is surprising and suggests that regulatory
sequences for each promoter might act independently. In-
deed, we have previously demonstrated that a fragment span-
ning -3280 to +37, with respect to the type I start site,
functions as a lymphocyte specific transcriptional regulatory
element in transgenic mice (22) . To better understand the
regulation ofIck transcription, we obtained amouse genomic
clone (32.1) containing the type II transcription start site (Fig.
1 b) . Adler et al . (13) previously reported that the murine
type 11 5' UTR sequence was not present in a clone extending
9 kb 5' of the type I transcription start site, indicating that,
in the mouse, the distal promoter lies at least 9 kb 5' to the
proximal promoter. Hence the organization ofthe mouse and
human kk transcriptional units is grossly conserved . We there-
fore asked whether type I and type II transcripts accumulate
in different lymphoid tissues.
Transcriptsfrom the Proximal and Distal Promoters Are Regu-
lated Differently In Viva Thymus, spleen, and PBLs all ex-
press kk transcripts (1-3, 8, 23) and protein (11, 24) . Inhuman
thymus, Ick transcripts containing both type I and type II
5' UTRs can be found (8) .
Using a probe specific for the type 15' UTR and the first
exon of the coding region of Ick (Ick probe, Fig . 2 a) in an
RNAase protection assay, mouse thymus RNA protects frag-
ments oftwo sizes (Fig. 2 b, lane 1) . As diagrammed in Fig.
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2 a, the 294-base fragment corresponds to type I mRNA .
The 110-base fragment corresponds to type II transcripts, the
sequence of which diverges from that of the probe 5' to the
splice acceptor site. Lane 3 of Fig . 2 b shows that while type
II Ick transcripts are found in LN cells, type IRNA is con-
spicuously absent . The 145-base band in lanes 2 and 3 ofFig.
2 b results from a CD4-specific probe added to these lanes
as an internal control . These observations suggest that ma-
ture peripheral T cells contain transcripts derived almost en-
tirely from the distal kk promoter. Importantly, similar differ-
ences in Ick expression are found between normal human
thymocytes and PBLs : thymocyte RNA hybridizes with
probes specific for the 5' UTRs of both type I and type II
transcripts, but peripheral lymphocyte RNA hybridizes only
to the probe for type II mRNAs (Fig. 3, lanes 1 and 6) .
We conclude that in bothman and mouse, type II kk tran-
scripts are present in both thymus and peripheral T cells,
whereas type I transcripts disappear at some point before the
exit of the mature thymocyte from the thymus . While this
change in steady-state mRNA abundance could be due to
a change in mRNA stability, it more likely reflects a cessa-
tion of transcription from the proximal promoter. This in-
terpretation is supported by the fact that themouse proximal
promoter directs the expression of heterologous genes, whose
transcript stability is presumably under separate control, to
the thymus and not to the peripheral lymphoid organs in
transgenic mice (reference 22 and our unpublished results) .
Expression ofType Iand Type II Transcripts InHuman Thymo-
cyte Subsets. Since the proximal promoter is active in the
thymus and inactive in mature peripheral T cells, we won-
dered whether this developmental switch occurred at a par-
ticular stage of T cell maturation in the thymus . We exam-
ined the expression of type I or type II Ick transcripts among
normal human thymocyte subpopulations defined on thebasis
of their expression of theT cell surface coreceptor molecules
CD4 and CD8 (Fig. 3) . Using oligonucleotide probes specific
for the 5'UTR of each type of transcript, both type I and
type II transcripts were detected in each of the CD4/CD8
thymocyte subsets studied . Although IckmRNA levels did
not differ greatly among the subsets, there was a trend to-
ward higher expression oftype II transcripts in the more ma-
ture, CD4+/CD8 - or CD4'/CD8+ (single-positive), thy-
mocytes (Fig. 3, lanes 3 and 4) than in the immature CD4- /
CD8 - (double-negative) thymocytes (Fig. 3, lane 5) . Con-
versely, the levels of type ImRNA were lower in the more
mature thymocyte subtypes, particularly the CD4 - cells
(Fig. 3, lane 4) . The technique used to isolate the subsets,
complement lysis, did not allow isolation ofintermediate matu-
rity CD4+/CD8' (double-positive) thymocytes from those
missing one or both of the CD4 or CD8 molecules. How-
ever, double-positive cells constitute the majority of thymo-
cytes and are thus represented in Fig . 3, lanes 1 and 2, ad-
mixed with the other, less abundant subtypes . Furthermore,
in other experiments, RNA from human CD4+/CD8+
thymocytes separated by FRCS® (Becton Dickinson and Co.,
Mountain View, CA) or peanut agglutinin contained abun-
dant kkmRNA (data not shown) . As complement lysis couldFigure 2 .
￿
Type I kk transcripts accumulate specifically in thymocytes. (a) Drawing (not to scale) of the kk RNA probe used to perform RNAse
protection analysis and the lengths protected by processed type I (294 bases) and type II (110 bases) kk mRNAs examined using this probe. The kk
probe is a 602-base single-stranded uniformly labeled RNA fragment complementary to a mouse genomic fragment that spans the type I 5' UTR,
the first exon of coding sequence, and flanking 5' (promoter) and 3' (intron) sequences and delimited by SfaNI and Ecc,R1 restriction sites. Distal
and proximal refer to the two kk promoter regions . AUG, translation initiation codon. Wavy arrows, transcription start sites. (b) RNAse protection
assay of mouse thymus and LN RNA . Lanes 1 and 3 contain kk probe ; lanes 2 and 3 contain a CD4 probe (described in Materials and Methods)
as a control, 145 bases of which are protected by normal CD4 mRNA .
not eliminate double-negative cells from the single-positives
in Fig. 3, lanes 3 and 4, we calculated the maximum propor-
tion ofhybridization signal potentially attributable to double-
negative cells using flow cytometry analysis ofthe contributing
pools (see Fig. 3, legend), and densitometry analysis of the
blots . Fig. 3, A and B, lanes 3 and 4, respectively, contain,
at most, 2%, 31%, 0.5%, and 2%, respectively, signal from
double-negative cells. Hence, single-positive cells in the thymus
do express some type I, as well as type II, Ick mRNA . We
conclude that type I and type II IckmRNA is present in each
ofthe human thymocyte subpopulations defined byCD4 and
CD8 expression, although we detected only small amounts
of type ImRNA in the CD4 -/CD8+ compartment . These
results are consistent with the recently reported findings of
Reynolds et al. (25), who showed a similar distribution of
differential promoter usage in flow cytometry-separated mouse
thymocytes and peripheral T cells .
Virtually all peripheralT cells are derived from bone marrow
progenitors that mature in the thymus (26) . These imma-
ture thymocytes pass through a CD4+/CD8+ stage that
gives rise to more differentiated single-positive cells that are
the immediate precursors of peripheral T cells (27) . Since
single-positive thymocytes contain type I lck transcripts while
peripheral T cells do not (Fig . 2 b and Fig . 3), the accumula-
tion of these transcripts must cease in the short interval im-
mediately preceding thymocyte emigration .
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Sequence Elements ofthe Distal Ick Promoter Are Highly Con-
served. Since the pattern of expression of type I and type
II Ick transcripts is closely conserved in human and mouse
lymphoid cells, one might expect to observe conservation in
cis-linked sequences involved in distal and proximal promoter
regulation. Indeed, we have previously reported that the human
and mouse proximal promoter sequences contain regions of
very high sequence identity (8) . To examine the distal pro-
moters for such conserved regions, we sequenced portions
of the SP12 cosmid and the phage clone 32.1 containing the
human and mouse distal promoters, respectively (Fig. 4) .
Alignment of the mouse and human distal promoter se-
quence reveals a high degree of linear conservation within
the first 200 bases 5' to the transcription start site (Fig. 4) .
Further aligned similarities are seen 5' to a 257 by segment
that appears in the mouse but not in the human. Notably,
there is also a high degree of sequence conservation in the
5'UTR for type II Ick transcripts. Significant similarities be-
tween the mouse and human sequences disappear 3' to the
splice donor site (data not shown), indicating that at least
the 5' end of this intron is not conserved.
The Proximal and Distal Ick Promoters Share Few Sequence
Elements. While a dot matrix comparison ofthe mouse and
human distal Ick promoter sequences demonstrates their high
degree of similarity (Fig. 5 a), very little similarity is noted
when the mouse distal promoter is compared to the mouseFigure 3 .
￿
Steady state levels of human type I and type II kk mRNA
in thymocyte subsets and peripheral T cells (PTC) . RNA samples from
whole thymus (lanes 1 and 2), subpopulations ofthymocytes isolated by
complement lysis with the indicated reagents (lanes 3-5), and PTC (lane
6) were analyzedby Northern blottingandsequential probing for the unique
5' UTRs ofhuman type I (A) and type 11 (B) hk transcripts . The compo-
sition of the lysis survivors was assessed by flow cytometry: lanes 1 and
2, 74% CD4+, 75% CD8+, 76% CD3+ ; lane 3, 95% CD4+, 8%
CD$dd, 96% CD3+ ; lane 4,3% CD4dd, 91% CD8', 99% CD3+ ; lane
5, 10% CD4wry dull, 19% CD8very dull 51% CD3+, 37% yS TCR+ .
proximal promoter (Fig. 5 b) . Nevertheless, careful compar-
ison revealed a sequence element in the distal promoter regions
ofboth the mouse and human that is also present in the prox-
imal promoter sequences ofboth species (Fig. 6 a) . This ele-
ment lacks similarities to the core consensus sequences of any
previously described cis-regulatory elements ofwhich we are
aware, but its "core" (5'-TGCTGGGG-3') does have some
similarities to sequences within regions known to bind the
murine MHC class I transcription factor H2TF-1 (includes
5'-GGCTGGGG-3') (28), as well as a chicken lysozyme si-
lencer (includes 5'-AGCTGGGG-3') (29) . A computer search
for the "core" 8-mer of the element among lymphoid-specific
promoters in the EMBL 19DNA database failed to find an
entry whose sequence conformed to all ofthe conserved regions
of the entire element . We also noted that the sequence sur-
rounding the element in the mouse distal promoter shows
a curiously symmetric series of nested direct repeats (Fig. 6
b) . Most of these repeats are also found in the same positions
in the human distal promoter sequence . These observations
are provocative and serve to focus attention on this region
as a putative binding site for factors regulating expression
of the Ick promoter (see below) . Several other short sequence
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segments (8-11 by in length) are shared between the prox-
imal and distal promoters within a species, but unlike the
element in Fig. 6 a are not shared by both species (data not
shown) .
We further examined thehuman and mouse proximal and
distal Ick promoter sequences for the presence of a variety
of previously identified eukaryotic cis-regulatory sequences .
We found that the human and mouse proximal promoters
contain a consensus sequence (5'-GGAAGTG-3') for E4TF-1,
a transcriptional regulator of adenovirus type 5 early region
4 (30, 31), located some 50 bases 5' to theIgH core enhancer
sequence previously noted by both Takadera et al . (6) and
Adler et al . (13) . A target sequence (5'-GTCGTCA-3') for
the cAMP response element binding protein was found in
the inverse orientation in the mouse distal promoter (bases
-318 to -324) . The so-called PU-box (5'-GAGGAA-3'), an
enhancer bound by thePU1 protein (the protooncogene Spi-1,
reference 32) in B lymphocytes and macrophages (33) is found
three times in the mouse distal promoter (-189 to -194,
-436 to -431, and -812 to -817) but not in the human
distal promoter. CCAAT and TATAA elements are present
in the human distal promoter sequence, but these are posi-
tioned far from the transcription start sites (bases -516 and
-536, respectively), and thus probably represent chance oc-
currences.
The Conserved Sequence Element Is a TargetforNuclear Pro-
tein Binding. To examine the possibility that the conserved
distal/proximal sequence element depicted in Fig . 6 a is an
important functional element, we tested its ability to speci-
fically bind components of nuclear protein extracts that pre-
sumably contain DNA-binding transcription factors, in a gel
mobility shift assay. Fig . 6 c demonstrates that a protein (or
protein complex) in lymphoid cell nuclei binds specifically
to a 29 by probe spanning this region of the mouse distal
promoter (Fig . 6 a, MD) . This binding (Fig. 6 c, lanes 1,
8, and 15) is specifically competed by an excess of unlabeled
probe (the MD competitor; Fig. 6 c, lanes 3, 10, and 17),
but not by the unrelated sequence OCT (Fig. 6 c, lanes 2,
9, and 16) that includes Oct-1 binding motifs (34) and also
binds nuclear proteins in this assay (data not shown) . Binding
is also not competed by a longerDNA fragment that con-
tains sequences flanking the mouse distal promoter transcrip-
tion start site (bases -38 to +44, data not shown) . Hence,
this nuclear extract-induced gel mobility shift is specific for
the probe.
The sequence dependence of the binding was further ex-
amined by competing with an excess of cold competitors
representing the similar sequences found in thehuman distal
(HD, differing by four bases from theMD probe), the mouse
proximal (MP, differing by eight bases), and two sequences
from the human proximal (HPa and HPb, differing by 14
and 21 bases, respectively) Ick promoters (Fig. 6 a) . (HPb is
quite divergent from MD but has more similarity to MR)
As seen in Fig. 6 c (lanes 4, 11, and 18), the very similar
sequence from the human distal promoter,HD, inhibitedMD
probe binding as effectively as unlabeledMD sequence. The
MP competitor failed to compete significantly in the experi-ment in Fig. 6 c (lanes S and 12) but did compete successfully
at much higher molar ratio (data not shown) in a sequence-
specific manner. This observation suggests that the DNA-
binding protein complex has some specificity for the MP se-
quence, but binds with a much lower affinity. The two
sequences from the human proximal promoter were unable
to compete effectively (Fig. 6 c, lanes 5, 6, 13, and 14) .
The gel mobility shifts in thymus have a slower mobility
than the otherwise similar shifts seen in spleen or liver, though
their sequence-specificity is the same (Fig. 6 c) . Hence, the
nature of the complex found in thymus is different than that
in total spleen, or in liver. By varying the conditions of the
gel shift assay, the mobility differences noted between thymus
and spleen or liver extracts aremuch more pronounced, indi-
cating that this is a real and consistent difference (data not
shown) .
We conclude that both lymphoid and nonlymphoid organs
contained nuclear proteins or complexes that specifically bind
the sequence element highlighted by the sequence compar-
isons, that the nature of the complexes varies by organ type,
and that the binding affinity in the gel mobility shift assay
is sensitive to increasing variations from the MD target se-
quence.
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Figure 4.
￿
Extended sequence similarity in the human and mouse distal kk promoter regions. The mouse sequence is at the top of each comparison .
Bases that match are linked by a colon . Sequences are 5' to 3'. Numbers are with respect to the predominant (llc) transcription start site (filled triangle)
reported by Takadera et al . (6) . The splice donor site is boxed. These sequence data have been assigned GenBank accession numbers M36823 (mouse)
and M36824 (human) .
TheHuman Distal Promoter Functions Independently in Trans-
genic Mice. Sequence analysis showed that cis promoter ele-
ments of the lck distal promoter have been conserved in evo-
lution and suggested that the corresponding trans-acting factors
responsible for tissue-specific and developmental regulation
of the distal promotermay also have been conserved . We tested
this hypothesis by assessing the ability of the human distal
promoter to function in a heterologous background, i.e., by
using it to drive a reporter gene in transgenic mice. Animals
bearing a transgene (SP12T) consisting of ahuman genomic
segment containing 2.5 kb of sequence 5' to the type II lck
mRNA transcription start site (subclone SP12, Fig. 1) driving
the SV40 large T antigen gene expressed SV40 T mRNA
in thymus and spleen, and faintly in heart, but not in liver
or kidney (Fig . 7) . The very small amount ofT antigen tran-
script detected in heart may represent that derived from the
blood lymphocytes contained within the heart at the time
of dissection rather than from the myocardium . Starting at
21 wk of age, mice bearing this transgene developed hemor-
rhagic tumors of the LN and spleen and gross enlargement
of the thymus . Tumors were not noted in the heart or in
any other non-lymphoid organs. Thus, unlike previously de-
scribed transgenic mice bearing a similar T antigen trans-
-826 TTTCTTGTCTTCCTCCTGAAACAGACTGTCAACAGTCGATCCTTAGGCACAGGATGACATGGATACGGCTCTGCCAGTGAATGTGG------------------------CTGCTGTTTT M
-562 TAGCCTGCCATTCACCTACCCTTGGCTATAATTAAAGCTTACTGGTCCAATGCCCTGAGGTGGCATGGGAAATGGTCTCTCGGCCTGGCCTGGCTGTAA H
-730 TACTATAGTACCTTGTCACCAACTATCTAACAGAGATAGATACTGTCCAGGTTCAACTCTGAACAAGAGATGCCTTTGGCTGTCCGGCTAAATTAAAGGCCACCCAGTTCTTACATAGCA M
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-610 CGGCTGGAGT-TGAGTGCAGCGCCATTTCCTTCCCTG-TGAGCTAAACTGTAGCTGCTGTGTTCTGCTCAC-GGGGGCAAAGGCTCTCTTTGGATCTCTTACCCAGGAGTATCTTGGAGG M
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H
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-203 ----------------------------------------------------------AAACCTCCCAGTGTCACCCTGGGACAGTAGGGGAAGATGGACCTGGTCTGGAGATGTAGGGG H
-138 ACCCAAGAGGCTGAGGGGGTCTAGGTCTATGGCAGCAGGAAGCCTGAGGTGCTGGAGGCTTGTGGTTGGGTTGCTGGGGCTGGGTTGGCTGCAGAGCCCTC---AGGAGACAGGAAGTCA M
-141 ACCCCCAGGGGCTGAGAGGCAGGGGTCTATGGTGG. " CAGGAAGCTTGGCGTGCTAGAGGGTTGTGGTTGGGCTGCTGGGGCCCGGTTGGCTGCGGAGCCCTCCGGAGGAGGCAGGAAGTCA H
+1
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-21 GGGTGGGACGTGGGCG ' " CGG , GGAGA ACAGGTGGTGGCTACGACGGCGAAGGGAGCTGAGACT--GTCCAGGCAGCCAGGTTAGGCCAGGAGGACCATGTGAATGGGGCCAGAGGGCTCCCGG H
+99 GCTGGG GGGGTACTGGGAACAACAGTGTAGAGGGGGGCAATGGTGGGAACCAGGCAACAGAACACTGCGTCTGTGGAGGCCTAGGCTCCTTAGGTGTACAGAAACCTTTCAGA M
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gene driven by the mouse proximal lck promoter, which de-
velop only thymic tumors (22), the human distal promoter
directedT antigenmRNA expression and T antigen-induced
transformation to the peripheral lymphoid organs as well as
to the thymus . The behavior of the distal and proximal
promoters in transgenic mice thus conforms to the expres-
sion patterns oftype I and type II kk transcripts demonstrated
in Figs . 2 and 3 .
We have demonstrated that the lck gene can be transcribed
via two separate promoters that behave in a developmentally
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Figure 5.
￿
The proximal and distal kk promoters
share little sequence similarity. (a) Dot matrix com-
parison of themouse and human distal kk promoter
region sequences . Each dot represents a match of 12
out of 16 bases . The 5' end of each sequence begins
at the lower left and thenumbers are baseswith re-
spect to the transcription start sites (arrows). (b) Dot
matrixcomparison ofthemouse proximal andmouse
distal kk promoter sequences . The former sequence
is takenfrom Garvin et al. (8) . parameters are as in a .
regulated fashion : while both promoters are active in thymo-
cytes, only the distal promoter is active in mature T cells.
One may conceive of three explanations for the presence of
dual lck promoters. First, the simple requirement for p56"
in both thymocytes and peripheral T cells may have driven
conservation ofa "constitutive" promoter (the distal promoter),
while the presence and activity of the proximal promoter is
genetically accidental and superfluous . The high degree of
sequence conservation noted between thehuman and mouse,
the persistence of a functional proximal promoter in both
species, and the lack of major sequence similarities between
the distal and proximal promoter sequences argue against this
hypothesis.b
-103
￿
-24
I
￿
I
CAGGAAGCCTGAGGTGCTGGAGGCTTGTGGTTGGGTTGCTGGGGCTGGGTTGGCTGCAGAGCCCTCAGGAGACAGGAA
C
exttacct: thyinus
OOinpCtltoc:
￿
- OCr ID HD MP HPa HPb
free
pmbe
spleen
The dual promoter system might also reflect the need for
continued expression of lck in the context of a changing tran-
scriptional milieu that could not support activation from a
single set of regulatory elements under all conditions. In this
model, the changing milieu would be driven not by the need
for modified kk expression but by the regulation of other
genes with related transcriptional control elements that must
be modulated in the process of thymocyte maturation . Con-
tradicting this hypothesis, we have shown that thymocytes
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Figure 6 .
￿
An element conserved
in the proximal and distal kk pro-
moters binds nuclear factors. (a)
Alignment of a promoter element
found in four kk promoter sequences
(Fig.4, and reference 8) . (-) Bases
that match the mouse distal pro-
moter sequence (top line) . MD, MP,
HD, HPa, and HPb : sequence of
double-stranded DNA segments
used as probe and competitors in c .
(b) Sequence ofthe mouse distal kk
promoter surrounding the con-
served element in a . Nested direct
repeats surrounding the core se-
quence (bold type) ofthe elementare
underlined and connected by a
dotted line. Nucleotide position
with respect to the transcription
start site is noted. (c) Gel mobility
shift assay. Nuclear protein extracts
were incubated with a double-
stranded 29-bp radiolabeled DNA
probe (MD, see a), with or without
the prior addition ofunlabeledcom-
petitors . The resulting protein :
DNA complexes were separated
from the faster moving free DNA
probe ("free probe") on a native
polyacrylamide gel . Binding ofthe
probe by proteins with nonspecific
affinity forDNA was reducedby the
prior addition of 1.5 ug of poly
dldC per reaction . Double-stranded
DNA competitors: -, none ; OCT,
(5'-GCAGAAGTATGCAAAGCA-
TGCATCTCAATTAGTCAG-3'),
from the SV40 enhancer B element,
target for the octamer binding pro-
tein, OBP-100 (34) ; Seea for com-
petitor designations . Upper and
lower arrows indicate bands of
different mobility seen in thymus,
spleen, or liver, respectively.
of all developmental stages as well as peripheral lymphocytes
transcribe effectively from the distal promoter.
It seemsmuch more likely that the dual kk promoter system
evolved as a mechanism for allowing differential regulation
under different developmental conditions : i .e., there is an ad-
vantage to be gained from controlling lck expression in pe-
ripheral lymphocytes in a manner different from that in thymo-
cytes undergoing selection and maturation .
While the nature ofthis advantage is obscure, it is impor-
-83 AGGCTTGTGGTTGGGTTGCTGGGGCTGGG Mouse Distal (MD)
-352 GT-G-G-G---A---G --------T---- Mouse Proximal (MP)
-86 . . .G-----------C--------- CC- . Human Distal (HD)
-420 TCA--G-A--G-TTTC--------AGAA- Human Proximal a (HPa)
-347 GT-AGG-GAACA-C-GG-GCTT-ATG-T- Human Proximal b (HPb)Figure 7.
￿
Expression ofthe SP12T transgeneinlymphoid tissues. Shown
is anRNAblot performed using samples derived fromtheindicated tissues
of a 6.5-wk-old SP12T transgene mouse. The blot was hybridized with
a probe specific for SV40T antigen sequences (see Materials and Methods) .
tant to recognize that type I and type II transcripts encode
identical proteins . Hence, the advantageous differential con-
trol must act at or prior to translation, i .e ., on the transcrip-
tion rate, nascent transcript processing,mRNA stability, or
translational efficiency. Differential transcriptional control
could simply reflect the need for more Ick mRNA in de-
veloping thymocytes, thus requiring a stronger promoter, as
in the mouse cx-amylase dual promoter system (35) . Alterna-
tively, response to certain stimuli, e.g., T cell activation, might
differ between the two Ick promoters . The quite dissimilar
yet evolutionarily conserved sequences of the 5' UTRs of type
I and type II Ick transcripts suggest the potential for differen-
tial stability or efficiency of translation . Indeed, we have pre-
viously demonstrated that murine type I transcripts contain
AUG codons within their 5' UTRs that reduce the transla-
tional efficiency of thesemRNAs (36) . The human and mouse
type II transcripts also have a single out-of-frameAUG codon
in their 5' UTRs, but the effect of this sequence on transla-
tion has not been tested .
Dual promoters have been described in several other eu-
karyotic contexts . In some cases, the differential regulation
of the two promoters appears to be due to stage- or organ-
ific factors (35, 37). In others, transcription from the distal
promoter interferes with transcription from the proximal pro-
moter, resulting in mutually exclusive promoter usage (38,
39) . Since the thymocyte subsetswe studied all contain tran-
scripts from both the proximal and distal Ick promoters, mutu-
ally exclusive usage due to transcriptional interferences is un-
likely . Instead, the lack of sequence similarity between the
proximal and distal promoters suggests control via different
trans-acting factors having different target sequences.
The mouse and human distal Ick promoters share a high
degree of primary sequence similarity. The validity of infer-
ring functional importance for regions ofthe promoter whose
sequences have been conserved in evolution depends on the
assumption that the trans-acting regulatory factors and their
binding specificities are also conserved . Our ability to target
SV40 T antigen-induced tumor formation to T cells found
in the peripheral lymphoid organs using the human Ick distal
promoter in transgenic mice shows that the human cis ele-
ments are sufficient to drive appropriate tissue-specific ex-
pression in a mouse milieu, lending credence to this approach .
The significance of the occurrence of canonical binding
sequences for E4TF1, CREB, and the PU.1 protein is ques-
tionable as none of them hasbeen implicated in T cell-specific
transcriptional regulation, and the sites for the latter two are
not conserved between species, Since both the proximal and
distal Ick promoters lack other convincing sequence elements
previously identified as the binding sites for trans-acting regula-
tory proteins, study of the regulation of the Ick promoters
is likely to reveal novel regulators of transcription . Indeed,
Fig. 6 indicates that the conserved sequence element serves
as a target for binding of nuclear proteins, and the behavior
of these proteins is different in thymocytes, splenocytes, and
hepatocytes . Detailed dissection of transcriptional control
mechanisms regulating Ick expression will almost certainly
provide insights into the control of thymocyte development
via gene activation, and may help define the function of
p56kk in T cells .
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